EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Elevated T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT) Expression and Immune Cell Dysfunction Characterize Complex Proteins Associated With SET1 (COMPASS)–Like Complex Gene–Mutated Pancreatic Ductal Adenocarcinoma (PDAC)

Shungang Zhang, Elaina R Daniels, Jake McGue, Ranga Sudharshan, Hongsun C Kim, Dafydd G Thomas, Santhoshi Krishnan, Timothy L Frankel, Erika Hissong, Arvind Rao, Naziheh Assarzadegan, Jiaqi Shi

Modern Pathology · 2026

DOI: 10.1016/j.modpat.2026.100972 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2026. Verfasst von Shungang Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Clinical Labs, University of Michigan, Ann Arbor, Michigan. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Receptors, Immunologic, Pancreatic Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, Cancer Center, University of Florida Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is highly resistant to immune therapies. Limited biomarkers, such as mismatch repair proteins, have been used to identify those who may respond to immunotherapy. We identified a subset of aggressive PDACs (⁓25%) carrying mutations in the complex of proteins associated with SET1-like complex genes (CLCGs), which can be used as new biomarkers for targeted immunotherapy. In this study, we compared the immune microenvironment of PDACs harboring CLCG mutations with matched wild-type PDACs using multiplex fluorescent immunohistochemistry and computational imaging techniques. We observed that CLCG-mutant PDACs were infiltrated with fewer CD4+ T cells and antigen-presenting cells (APCs) but elevated immune checkpoint T cell immunoreceptor with Ig and ITIM domains (TIGIT) expression on CD4+ T cells and APCs. There was no difference in the expressions of other immune checkpoints, such as programmed death-1 receptor ligand and T-cell immunoglobulin and mucin domain-containing protein 3. More CD4+ T cells near epithelial cells (tumor cells) and APCs expressed TIGIT in CLCG-mutant PDACs. Additionally, CLCG-mutant PDACs displayed a malfunctional immune cell crosstalk. Single-cell RNA-sequencing data confirmed the elevated TIGIT expression on CD4+ T cells and increased exhausted CD4+ T cells in CLCG-low PDACs. These findings uncovered the unique underlying mechanisms of immune suppression in CLCG-deficient PDACs and identified CLCG as potential biomarkers to identify those who may benefit from TIGIT-targeting immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalReceptors, ImmunologicPancreatic NeoplasmsBiomarkers, TumorHumansMutationTumor MicroenvironmentFemaleLymphocytes, Tumor-InfiltratingCD4-Positive T-Lymphocytes

Stichwörter der Autor:innen

CD4(+) T cellsepigenetic regulationimmunosuppressionpancreatic ductal adenocarcinomatumor microenvironment

Substanzen

Receptors, ImmunologicTIGIT protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology & Clinical Labs, University of Michigan, Ann Arbor, Michigan.
  • Department of Surgery, University of Michigan, Ann Arbor, Michigan.
  • Department of Computational Medicine and Bioinformatics, Radiation Oncology, and Biostatistics, University of Michigan, Ann Arbor, Michigan.
  • Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital, Weill-Cornell Medicine, New York, New York.
  • Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, Florida.
  • Department of Pathology & Clinical Labs, University of Michigan, Ann Arbor, Michigan. Electronic address: jiaqis@umich.edu.

Förderung

  • NCI NIH HHS
  • NIH HHS
  • Cancer Center, University of Florida Health
  • National Institutes of Health
  • University of Michigan
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Zhang, S., Daniels, E. R., McGue, J., Sudharshan, R., Kim, H. C., Thomas, D. G., Krishnan, S., Frankel, T. L., Hissong, E., Rao, A., Assarzadegan, N., & Shi, J. (2026). Elevated T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT) Expression and Immune Cell Dysfunction Characterize Complex Proteins Associated With SET1 (COMPASS)–Like Complex Gene–Mutated Pancreatic Ductal Adenocarcinoma (PDAC). Modern Pathology. https://doi.org/10.1016/j.modpat.2026.100972

Vancouver

Zhang S, Daniels ER, McGue J, Sudharshan R, Kim HC, Thomas DG, et al. Elevated T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT) Expression and Immune Cell Dysfunction Characterize Complex Proteins Associated With SET1 (COMPASS)–Like Complex Gene–Mutated Pancreatic Ductal Adenocarcinoma (PDAC). Modern Pathology. 2026. doi:10.1016/j.modpat.2026.100972

BibTeX
@article{Zhang2026,
  author = {Zhang, Shungang and Daniels, Elaina R and McGue, Jake and Sudharshan, Ranga and Kim, Hongsun C and Thomas, Dafydd G and Krishnan, Santhoshi and Frankel, Timothy L and Hissong, Erika and Rao, Arvind and Assarzadegan, Naziheh and Shi, Jiaqi},
  title = {Elevated T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT) Expression and Immune Cell Dysfunction Characterize Complex Proteins Associated With SET1 (COMPASS)–Like Complex Gene–Mutated Pancreatic Ductal Adenocarcinoma (PDAC)},
  journal = {Modern Pathology},
  year = {2026},
  doi = {10.1016/j.modpat.2026.100972}
}
Kostenlos starten →